Apexigen, Inc. | SEC Filings

Form	Description	Filing date	View
DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	Jul 17, 2020	View HTML 0001213900-20-017827.pdf 0001213900-20-017827.rtf 0001213900-20-017827.xls
EFFECT	EFFECT	Jan 28, 2021	View HTML 9999999995-21-000318.pdf 9999999995-21-000318.rtf 9999999995-21-000318.xls
EFFECT	EFFECT	Jul 05, 2022	View HTML 9999999995-22-001963.pdf 9999999995-22-001963.rtf 9999999995-22-001963.xls
EFFECT	EFFECT	Sep 09, 2022	View HTML 9999999995-22-002645.pdf 9999999995-22-002645.rtf 9999999995-22-002645.xls
EFFECT	EFFECT	Sep 09, 2022	View HTML 9999999995-22-002644.pdf 9999999995-22-002644.rtf 9999999995-22-002644.xls
EFFECT	EFFECT	Mar 21, 2023	View HTML 9999999995-23-000622.pdf 9999999995-23-000622.rtf 9999999995-23-000622.xls
EFFECT	EFFECT	Apr 07, 2023	View HTML 9999999995-23-000864.pdf 9999999995-23-000864.rtf 9999999995-23-000864.xls
EFFECT	EFFECT	Apr 07, 2023	View HTML 9999999995-23-000863.pdf 9999999995-23-000863.rtf 9999999995-23-000863.xls
SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Feb 12, 2021	View HTML 0001213900-21-009068.pdf 0001213900-21-009068.rtf 0001213900-21-009068.xls
425	Filing of certain prospectuses and communications in connection with business combination transactions	Mar 18, 2022	View HTML 0001193125-22-078903.pdf 0001193125-22-078903.rtf 0001193125-22-078903.xls

Data provided by Kaleidoscope.